Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR T) therapy has demonstrated remarkable efficacy in patients with relapsed/refractory multiple myeloma, and now there are two US Food and Drug Administration-approved BCMA-directed CAR T products. However, despite high in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T. Melnekoff, Yogita Ghodke‐Puranik, Gunjan L. Shah, Alexander M. Lesokhin, Sergio Giralt, Santiago Thibaud, Adriana Rossi, Cesar Rodriguez, Larysa Sanchez, Joshua Richter, Shambavi Richard, Hearn Jay Cho, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Urvi A. Shah, Sham Mailankody, Samir Parekh
Materialtyp: Artigo
Språk:engelska
Publicerad: 2022
Länkar:https://doi.org/10.1182/blood.2022017848
https://ashpublications.org/blood/article-pdf/141/7/756/2034470/blood_bld-2022-017848-main.pdf
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Internet

https://doi.org/10.1182/blood.2022017848
https://ashpublications.org/blood/article-pdf/141/7/756/2034470/blood_bld-2022-017848-main.pdf

Liknande verk